Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial
| Authors | |
|---|---|
| Year of publication | 2003 |
| Type | Article in Periodical |
| Magazine / Source | Lung Cancer |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | Non Small Cell Lung Cancer; Stage IIIb and IV; Gemcitabine; Cisplatin; Carboplatin |
| Description | The ranomized, muticenter, phase III trial was conducted to compare the tolerability of gemcitabine plus cisplatine (GP) vs. gemcitabine plus carpolatin (GC). The enroled patients in GC and GP arm were balanced for demographic and disease characteristics. Both GP and GC are ffective options, the GC arm offering the advantage to pts unable to receive cisplatin. |
| Related projects: |